InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Adawi Kamal, 首席财务官. Insider active across 2 companies, notably EXAGEN INC.. Aggregated, 10 disclosures have been published. Split: 0 buy · 4 sells. Total volume traded: €51k. History available since 4 February 2022. The latest transaction was filed on 15 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Adawi Kamal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
25,000 股0Common StockSEC:0001193125-26-015323:0
75,000 股0Common StockSEC:0001193125-25-245106:0
9,297 股@ US$1.908922.8% 占其流量Common StockSEC:0001274737-24-000017:0
75,000 股0Common StockSEC:0001274737-24-000013:0
6,738 股@ US$1.949117.1% 占其流量Common StockSEC:0001274737-24-000009:0
3,667 股@ US$2.299311.0% 占其流量Common StockSEC:0001274737-23-000014:0
100,000 股0Common StockSEC:0001274737-23-000012:0
5,821 股@ US$2.692120.4% 占其流量Common StockSEC:0001274737-23-000007:0
3,241 股@ US$7.1228.7% 占其流量Common StockSEC:0001274737-22-000017:0
63,500 股0Common StockSEC:0001274737-22-000009:0
10 条申报中的 10 条
About Adawi Kamal
Adawi Kamal is Directeur Financier. There are 10 filings in total, and across the sampled recent filings dated from 2022-02-08 to 2026-01-16, sales total EUR 51102 and purchases total EUR 0. The companies listed are EXAGEN INC., where the stated role is CFO and Corporate Secretary, and Fate Therapeutics INC, where the stated role is Chief Financial Officer.
